SCHEMBL17810062

SCHEMBL17810062

Brc1ccc2c(c1)c1cc(Br)cc3c1n2-c1ccccc1-c1ccccc1-3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 1/20 0.39
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
IDO2 Q6ZQW0 1/20 0.38
DNMT1 P26358 1/20 0.36
TSPO P30536 1/20 0.35
GABRA1 P14867 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRA2 P47869 2/20 0.33
GABRB2 P47870 2/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 1/20 0.33
GABRA3 P34903 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PDE4B Q07343 1/20 0.33
DNM1 Q05193 1/20 0.33
CCNB2 O95067 3/20 0.32
CDK1 P06493 3/20 0.32
CCNB1 P14635 3/20 0.32
GSK3B P49841 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17810073 0.89 DUSP3 (0.37) PTPRCIDO1TDO2IDO2TSPO
SCHEMBL17810060 0.88 IDO1 (0.38) PTPRCIDO1TDO2IDO2DNMT1
SCHEMBL1832121 0.87 DNMT1 (0.41) PTPRCIDO1TDO2IDO2DNMT1
SCHEMBL26529663 0.81 DNMT1 (0.39) PTPRCIDO1TDO2IDO2DNMT1
SCHEMBL17810053 0.78 IDO1 (0.44) PTPRCIDO1TDO2IDO2TSPO
SCHEMBL26529975 0.78 GABRA1 (0.43) PTPRCIDO1TDO2IDO2DNMT1
SCHEMBL20707497 0.78 DNMT1 (0.41) IDO1TDO2IDO2DNMT1GABRA1
SCHEMBL30451809 0.78 DNMT1 (0.41) IDO1TDO2IDO2DNMT1GABRA1
SCHEMBL26529649 0.77 POLB (0.38) IDO1TDO2IDO2DNMT1TSPO
SCHEMBL30524996 0.77 IDO1 (0.38) IDO1TDO2IDO2DNMT1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9502667-B2 Organic electroluminescence IDEMITSU KOSAN CO., LTD. (JP) 2016-11-22 US disclosed
US-9502667-B2 Organic electroluminescence IDEMITSU KOSAN CO., LTD. (JP) 2016-11-22 US disclosed
US-20160163998-A1 ORGANIC ELECTROLUMINESCENCE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-09 US disclosed
US-20160163998-A1 ORGANIC ELECTROLUMINESCENCE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160163998-A1 ORGANIC ELECTROLUMINESCENCE EML4, ODC1, NDC1 PTPRC 1457/4885IDO1 3015/4885TDO2 2619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.